0.9945
22-نوفمبر-24 16:44:58
15 متأخرة بدقائق
الأسهم
+0.0045
+0.45%
نطاق اليوم
0.9602 - 1.0200
ISIN
N/A
المصدر
NASDAQ
Verrica Pharmaceuticals Announces FDA Filing Acceptance of Resubmitted New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
17 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire
Verrica Pharmaceuticals Presents Positive Data From Clinical Studies Evaluating the Safety and Efficacy of VP-102 in Molluscum and External Genital Warts at the 2021 Winter Clinical Dermatology Conference
19 يناير 2021 07:00:00 بحسب Nasdaq GlobeNewswire